BRIEF-Ocugen Reports Full Year 2020 Financial Results

Reuters2021-03-18

March 18 (Reuters) - Ocugen Inc :

* OCUGEN INC - CASH, CASH EQUIVALENTS, AND RESTRICTED CASH TOTALED $24.2 MILLION AS OF DECEMBER 31, 2020, COMPARED TO $7.6 MILLION AS OF DECEMBER 31, 2019

* OCUGEN - PREPARING TO FILE INVESTIGATIONAL NEW DRUG APPLICATION TO INITIATE FIRST TWO CLINICAL TRIALS FOR OCU400 IN SECOND HALF OF THIS YEAR

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Kokonut
2021-03-18
Kokonut
Upz
AlfredGJX
2021-03-18
AlfredGJX
Up

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2120215281?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-03-18 19:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2120215281","market":"us","top_or_hot":-1,"title":"BRIEF-Ocugen Reports Full Year 2020 Financial Results","media":"Reuters","content":"<html><body><p>March 18 (Reuters) - Ocugen Inc   :</p><p>   * OCUGEN INC - CASH, CASH EQUIVALENTS, AND RESTRICTED CASH TOTALED $24.2 MILLION AS OF DECEMBER 31, 2020, COMPARED TO $7.6 MILLION AS OF DECEMBER 31, 2019</p><p>   * OCUGEN - PREPARING TO FILE INVESTIGATIONAL NEW DRUG APPLICATION TO INITIATE FIRST TWO CLINICAL TRIALS FOR OCU400 IN SECOND HALF OF THIS YEAR</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Ocugen Reports Full Year 2020 Financial Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Ocugen Reports Full Year 2020 Financial Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-18 19:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>March 18 (Reuters) - Ocugen Inc   :   * OCUGEN INC - CASH, CASH EQUIVALENTS, AND RESTRICTED CASH TOTALED $24.2 MILLION AS OF DECEMBER 31, 2020, COMPARED TO $7.6 MILLION AS OF DECEMBER 31, 2019   * ...</p>\n\n<a href=\"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OCGN","symbol_name":"Ocugen","start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2120215281","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2120215281","pubTimestamp":1616067189,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"March 18 (Reuters) - Ocugen Inc   :   * OCUGEN INC - CASH, CASH EQUIVALENTS, AND RESTRICTED CASH TOT","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OCGN":"Ocugen"},"translate_title":"简介-OCUGEN报告2020年全年财务业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OCGN":0.9},"content_text":"March 18 (Reuters) - Ocugen Inc   :   * OCUGEN INC - CASH, CASH EQUIVALENTS, AND RESTRICTED CASH TOTALED $24.2 MILLION AS OF DECEMBER 31, 2020, COMPARED TO $7.6 MILLION AS OF DECEMBER 31, 2019   * OCUGEN - PREPARING TO FILE INVESTIGATIONAL NEW DRUG APPLICATION TO INITIATE FIRST TWO CLINICAL TRIALS FOR OCU400 IN SECOND HALF OF THIS YEARSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":327892211,"gmtCreate":1616075277133,"gmtModify":1704790579682,"author":{"id":"3573705635178867","authorId":"3573705635178867","name":"Kokonut","avatar":"https://static.tigerbbs.com/88ae7a2c7b1134cd0591f44de9fd80f0","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3573705635178867","authorIdStr":"3573705635178867"},"htmlText":"Upz","listText":"Upz","text":"Upz","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/327892211","repostId":2120215281,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":327183183,"gmtCreate":1616069833142,"gmtModify":1704790483214,"author":{"id":"3577928644113155","authorId":"3577928644113155","name":"AlfredGJX","avatar":"https://static.tigerbbs.com/c665ba6cb70a8ee99cf786716110d953","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3577928644113155","authorIdStr":"3577928644113155"},"htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/327183183","repostId":2120215281,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":5,"commentSize":2,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2120215281"}